Prosecution Insights
Last updated: April 19, 2026
Application No. 17/900,023

METHOD AND TRANSCATHETER ANNULOPLASTY SYSTEM FOR CONTRACTING HEART TISSUE

Non-Final OA §102§103§112
Filed
Aug 31, 2022
Examiner
PASQUALINI, HANNA LOUISE
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Hangzhou Valgen Medtech Co. Ltd.
OA Round
1 (Non-Final)
47%
Grant Probability
Moderate
1-2
OA Rounds
3y 7m
To Grant
72%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allow Rate
7 granted / 15 resolved
-23.3% vs TC avg
Strong +25% interview lift
Without
With
+25.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
51 currently pending
Career history
66
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
47.8%
+7.8% vs TC avg
§102
18.0%
-22.0% vs TC avg
§112
30.3%
-9.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 15 resolved cases

Office Action

§102 §103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claim 27-38 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Applicant’s election of 1 in the reply filed on 10/03/2025 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Information Disclosure Statement The information disclosure statement filed 08/31/2022 fails to comply with the provisions of 37 CFR 1.97, 1.98 and MPEP § 609 because a translated copy of the internation search report has not been provided. It has been placed in the application file, but the information referred to therein has not been considered as to the merits. Applicant is advised that the date of any re-submission of any item of information contained in this information disclosure statement or the submission of any missing element(s) will be the date of submission for purposes of determining compliance with the requirements based on the time of filing the statement, including all certification requirements for statements under 37 CFR 1.97(e). See MPEP § 609.05(a). Claim Objections Claims 1, 5-9, 12-15, 20, 22-23, and 25-26 are objected to because of the following informalities: Claims 1, 13, 20, and 22 recites “first of the first plurality of anchoring component” but should recite “first of the first plurality of anchoring components” Claims 1, 14, and 22 recites “of remaining of the plurality or anchoring components” but should recite “of the remaining anchoring components of the plurality of anchoring components” Claims 5 and 7 recites “an adjusting apparatus for delivery and controlling” but should recite “an adjusting apparatus for delivering and controlling” Claim 6 recites “driving the retractor being to wind” but should recite “driving the retractor to wind” Claim 8 recites “drive the retractor ao as to wind” but should recite “drive the retractor to wind” Claim 9 recites “the delivery member being passed” but should recite “the delivery member is passed” Claim 9 recites “the delivery sheath to the spacer” but should recite “the delivery sheath against the spacer” Claim 9 recites “the spacer” but should recite “the at least one spacer” Claim 12 recites “and inserted into the delivery sheath” but should recite “and is inserted into the deliver sheath” Claims 15 and 23 recites “to couple the tightening string” but should recite “to couple to the tightening string” Claims 22 and 26 recites “a left wall and a right ventricle wall” but should recite “a left wall or a right ventricle wall” Claim 22 recites “a part of the anchoring component exposed” but should recite “a part of the anchoring component is exposed” Claim 25 recites “after the anchoring component being implanted” but should recite “after the anchoring component is implanted” Appropriate correction is required. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “Anchoring components” in claims 1, 10—15, 17, 19-20, and 22-25 “Delivery member” in claims 1-3, 6, 9-11, and 14 “Adjusting apparatus” in claims 5 and 8 “Anchoring apparatus” in claims 12-14, 17-18, and 23 “Anchoring member” in claims 15-17 and 23 “Threading structure” in claims 15-17 and 23 “Blocking member” in claims 18-19 and 24-25 “Guide apparatus” in claims 20 Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. For example, “Anchoring components” structure is shown in figures 8-10 For example, “Delivery member” is described in paragraph [0052] and [0054] as “circular, oblate, rectangular, square or other shapes” and can be a “elongated string including two head ends” For example, “Adjusting apparatus” is described in paragraph [0095] as possibly including “a threading rod 82, a rotating tube 84 and an outer sheath 86” For example, “Anchoring apparatus” is described in paragraph [0073] as being “made of metal materials or polymer materials, preferably metal material with higher hardness such as stainless steel” and including “the driving tube 12 and a connecting tube sleeved on outside the driving tube 12” For example, “Anchoring member” structure is shown in figures 8-10 For example, “Threading structure” is described in paragraph [0066] as “a threading eyelet” For example, “Blocking member” is described in paragraph [0081] as made of “shape memory materials such as but not limited to shape memory alloys, including nickel-titanium, nickel-titanium-based shape memory alloys, copper-based shape memory alloys, iron-based shape memory alloys, etc; and shape memory polymers, including high molecular weight polynorbornene, polycaprolactone” For example, “Guide apparatus” is described in paragraph [0047] as possibly being “a first guide sheath 71 and a second guide sheath 72 inserted into the first guide sheath 71.” If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-26 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1, 3, 6, 9, and 22 refer to a contraction in “size” of the heart tissue, but it is unclear if the heart tissue itself is changing in size or the opening of the annulus is what is changing in size. Claim 11-12, 14-15, 17, 19, and 22-25 recite “the anchoring component” without proper antecedent basis, it is unclear if “the anchoring component” is the same as “a plurality of anchoring components,” “a first of the plurality of anchoring component,” or “each of remaining of the plurality of anchoring components” Claim 23 recites “the lumen” without proper antecedent basis. Dependent claims are likewise rejected Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-16, 20-22, and 26 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kasher (US 20210145584 A). Regarding claim 1, Kasher teaches a method for contracting heart tissue using a transcatheter annuloplasty system (fig 3a-3b, [0352]), wherein the transcatheter annuloplasty system comprises a plurality of anchoring components (anchors 120, fig 3a-3b, [0352]), a tightening string (part of wire 112 extending through anchors, fig 3a-3b, [0352]) and a delivery member (part of wire 112 excess that is cut and removed [0352], or second wire [0069]), the tightening string and the delivery member are both flexible (fig 3a-3b, [0348]), a distal end of the tightening string is coupled to a first of the plurality of anchoring component ([0352]) a distal end of the delivery member is coupled to a proximal end of the tightening string ([0352], is coupled before being cut), and the method comprises: implanting the first of the plurality of anchoring component into the heart tissue, the tightening string entering a body of a patient along with the first of the plurality of anchoring component ([0352], wire delivered with anchor), and a proximal end of the delivery member extending outside the body ([0346] , see percutaneous); delivering each of remaining of the plurality of anchoring components, along the delivery member, to the tightening string ([0007], fig 3a-b), and implanting each of remaining of the plurality of anchoring components into the heart tissue in sequence ([0007], fig 3a-b),; tightening the tightening string thereby adjusting a spacing of the plurality of anchoring components to contract a size of the heart tissue (([0352]). Regarding claim 2, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the method further comprises: separating the delivery member from the tightening string, and withdrawing the delivery member (part of wire 112 excess that is cut and removed [0352]). Regarding claim 3, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises a retractor ([0255], wire tensioning mechanism), tightening the tightening string comprises: delivering the retractor, along the delivery member to the tightening string (can be attached to anchor, therefore delivered along wire [0352]); before the delivery member is separated from the tightening string (anchors are delivered before wire is cut [0352]), driving the retractor to wind the tightening string to tighten the tightening string until the heart tissue contracts to a desired size ([0255]). Regarding claims 4 and 7, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein when the retractor stops winding the tightening string, the tightening string is locked by the retractor ([0259]). Regarding claims 5 and 8, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises an adjusting apparatus for delivery and controlling the retractor ([0269], adjustment tool); driving the retractor to wind the tightening string comprises: driving the adjusting apparatus to drive the retractor, so as to wind the tightening string ([0269], adjustment tool). Regarding claim 6, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises a retractor([0255], wire tensioning mechanism), tightening the tightening string comprises: delivering the retractor, along the delivery member, to the tightening string (can be attached to anchor, therefore delivered along wire [0352]); before the delivery member is separated from the tightening string (anchors are delivered before wire is cut [0352], driving the retractor being to wind the tightening string; after the delivery member is separated from the tightening string ([0255]), driving the retractor to continue winding the tightening string until the heart tissue contracts to a desired size (the tensioning mechanism does this. Regarding claim 9, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises a locking pin ([0538]); tightening the tightening string comprises: before the delivery member is separated from the tightening string, tightening the tightening string until the heart tissue contracts to a desired size ([0352]); delivering the locking pin, along the delivery member (see fig 40a), to the tightening string; driving the locking pin to lock the tightening string ([0536]). Regarding claim 10, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises at least one spacer ([0012]), the method further comprises: delivering the at least one spacer in sequence, along the delivery member, to the tightening string ([0085], fig 22a), and one of the at least one spacer being provided between at least two adjacent anchoring components [0012]. Regarding claim 11, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises a delivery sheath (delivery tool 150, fig 2a), and the anchoring component is movably inserted therein (fig 2a); delivering the at least one spacer in sequence, along the delivery member, to the tightening string ([0085], fig 22a), comprises: after the proximal end of the delivery member being passed through one of the at least one spacer ([0085], must be passed proximal end to be delivered), pushing the spacer to be delivered along the delivery member (fig 22a); abutting a distal end of the delivery sheath to the spacer (fig 22 a, at slot delivery sheath and spacer are abutted); pushing the delivery sheath to move distally, to push the spacer to continue moving, along the delivery member, until the spacer is delivered onto the tightening string (fig 22a, [0482-0483], spacers are moved liked anchors, pushing the delivery sheath to the target site and pushing the anchor drive moves the spacers along the delivery member). Regarding claim 12, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises a delivery sheath and an anchoring apparatus (anchor driver, [0014]), the anchoring component is detachably coupled to a distal end of the anchoring apparatus and inserted into the delivery sheath ([0014], [0346]), the anchoring apparatus is configured to drive the anchoring component to be implanted into the heart tissue ([0014]). Regarding claim 13, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein implanting the first of the plurality of anchoring component into the heart tissue comprises: detachably coupling the first of the plurality of anchoring component to the distal end of the anchoring apparatus and inserting the first of the plurality of anchoring component into the delivery sheath (fig 2a, [0346]); pushing the delivery sheath until a distal end of the delivery sheath abuts the heart tissue (fig 2a); driving the anchoring apparatus to drive the first of the plurality of anchoring component to be implanted into the heart tissue (fig 2a). Regarding claim 14, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein delivering each of remaining of the plurality of anchoring components, along the delivery member, to the tightening string and implanting each of remaining of the plurality of anchoring components into the heart tissue in sequence comprises: detachably coupling one of the remaining of the plurality of anchor components to the distal end of the anchoring apparatus and inserting the one of the remaining of the plurality of anchor components into the delivery sheath ([0352], fig 3a); coupling the anchoring component to the proximal end of the delivery member ([0352], fig 3a); pushing the delivery sheath until a distal end of the delivery sheath abuts the heart tissue (fig 3a), and the anchoring component is delivered (fig 3a), along with a pushing of the delivery sheath (fig 2a pushing the delivery sheath to the target site delivers the anchors), along the delivery member to the tightening string (fig 3a, sheath travels along center wire); driving the anchoring apparatus to drive the anchoring component to be implanted into the heart tissue ( fig 3a). Regarding claim 15, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the anchoring component comprises an anchoring member (element 130, fig 1) and a threading structure (aperture 146, fig 1), the anchoring member is configured to be anchored into the heart tissue ([0344]), and the threading structure is configured to couple the tightening string ([0344]). Regarding claim 16, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the anchoring member is rotated to anchor into the heart tissue ([0010]), and the threading structure is rotatably sleeved on the anchoring member ([0376]). Regarding claim 20, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises a guide apparatus (tube 252, fig 5a) having a channel (slit 256, fig 5a, the method further comprises: before the first of the plurality of anchoring component is implanted into the heart tissue, establishing a delivery pathway from outside the body to the heart tissue through the guide apparatus ([0379]). Regarding claim 21 and 26, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the heart tissue is one of a mitral annulus, a tricuspid annulus, a left ventricular wall, and a right ventricular wall ([0288]). Regarding claim 22, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher teaches a method for contracting heart tissue using a transcatheter annuloplasty system (fig 3a-3b, [0352]), wherein the transcatheter annuloplasty system comprises a plurality of anchoring components (anchors 120, fig 3a-3b, [0352]), a tightening string (part of wire 112 extending through anchors, fig 3a-3b, [0352]) and a delivery sheath part of wire 112 excess that is cut and removed [0352], or second wire [0069]); the tightening string is flexible (fig 3a-3b, [0348]),, a distal end of the tightening string is coupled to a first of the plurality of anchoring component ([0352]), a tube wall of the delivery sheath (tube 252, fig 5a) defines a through slot extending from a distal end of the delivery sheath towards a proximal end of the delivery sheath (slit 256, fig 5a),, and a part of the anchoring component exposed from the through slot (fig 5a-5b), the method comprises: implanting the first of the plurality of anchoring component into the heart tissue ([0352], fig 2a or 3a); delivering each of remaining of the plurality of anchoring components to the tightening string and implanting each of remaining of the plurality of anchoring components into the heart tissue in sequence string ([0007], fig 3a-b); and tightening the tightening string to adjust a spacing of the anchoring components to contract a size of the heart tissue ([0352]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 17-19 and 23-25 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kasher (US 20210145584 A) in view of Davidson (US 20070118151 A1). Regarding claim 17, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein a tube wall of the delivery sheath defines a through slot extending from a distal end of the delivery sheath towards a proximal end of the delivery sheath (slit 256, fig 5a), and the through slot interconnects with a lumen of the delivery sheath ([0386]), a distal end of the through slot defines an opening (fig 5a), and the method further comprises: after the anchoring component is detachably coupled to the distal end of the anchoring apparatus, withdrawing the anchoring apparatus proximally so that the anchoring member is received into the lumen of the delivery sheath, such that the tightening string is separated from the anchoring member (fig 5a, fig 17a). Kasher fails to teach wherein the threading structure is at least partially located outside the delivery sheath. Davidson teaches a system for treating a patient’s heart valve (abstract) with a threading structure is at least partially located outside the delivery sheath (fig 28a-29c). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device taught by Kasher by including a partially external anchor thread, as taught by Davidson, in order to combine prior art elements, such as a slot and anchor design, according to a known method to yield predictable results of an anchor staying in a secure and fixed position that prevents entangling and allows freedom of suture adjustments ([0117-0118]). Regarding claim 18, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises a blocking member (spur and pull wire, [0057], [0452]), the blocking member extends along an axial direction of the delivery sheath (element 478, fig 18, a distal end of the blocking member is adapted to a circumference of the delivery sheath to close the opening of the through slot (element 480, fig 18); the method also comprises: before the anchoring apparatus is withdrawn proximally, pulling the blocking member proximally to open the opening of the through slot ([0451-0452], [0454]); after the anchoring apparatus is withdrawn proximally, releasing the blocking member such that the blocking member closes the opening of the through slot ([0451-0452], [0454]). Regarding claim 19, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the method further comprises: after the anchoring component is implanted into the heart tissue, pulling the blocking member proximally to open the opening of the through slot to release the anchoring component from the delivery sheath ([0451-0452], [0454]). Regarding claim 23, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises an anchoring apparatus for driving the anchoring component to be implanted into the heart tissue (anchor driver, [0014]),; the anchoring component comprises an anchoring member (element 130, fig 1) and a threading structure (aperture 146, fig 1); the anchoring member is configured to be anchored into the heart tissue ([0344]); the threading structure is configured to couple the tightening string ([0344]); a distal end of the through slot defines an opening; the method also comprises: detachably coupling the anchoring component to a distal end of the anchoring apparatus and inserting the anchoring component into the delivery sheath([0014], [0346], fig 2a), so that the anchoring component is received in the lumen of the delivery sheath. Kasher fails to teach wherein the threading structure is at least partially located outside the delivery sheath. Davidson teaches a system for treating a patient’s heart valve (abstract) with a threading structure is at least partially located outside the delivery sheath (fig 28a-29c). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device taught by Kasher by including a partially external anchor thread, as taught by Davidson, in order to combine prior art elements, such as a slot and anchor design, according to a known method to yield predictable results of an anchor staying in a secure and fixed position that prevents entangling and allows freedom of suture adjustments ([0117-0118]). Regarding claim 24, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the transcatheter annuloplasty system further comprises a blocking member (spur and pull wire, [0057], [0452]), the blocking member extends along an axial direction of the delivery sheath (element 478, fig 18), a distal end of the blocking member is adapted to a circumference of the delivery sheath to close the opening of the through slot (element 480, fig 18); the method also comprises: before the anchoring component is inserted into the delivery sheath, pulling the blocking member proximally to open the opening of the through slot ([0451-0452],[0454]); after the anchoring component is inserted into the delivery sheath, releasing the blocking member so that the blocking member closes the opening of the through slot ([0451-0452], [0454]). Regarding claim 25, as best understood based on the 35 U.S.C. 112(b) issues identified above, Kasher further teaches wherein the method further comprises: after the anchoring component being implanted into the heart tissue, pulling the blocking member proximally to open the opening of the through slot to release the anchoring component from the delivery sheath ([0451-0452], [0454]). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to HANNA LOUISE PASQUALINI whose telephone number is (703)756-1984. The examiner can normally be reached Telework 7:30PM-5:00PM EST M-F (occasionally off Fridays). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jerrah Edwards can be reached at (408) 918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /H.L.P./ Examiner, Art Unit 3774 /THOMAS C BARRETT/SPE, Art Unit 3799
Read full office action

Prosecution Timeline

Aug 31, 2022
Application Filed
Jan 14, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12575969
DEVICE AND METHOD FOR TREATMENT OF RETINAL DETACHMENT AND OTHER MALADIES OF THE EYE
2y 5m to grant Granted Mar 17, 2026
Patent 12396854
SYSTEMS, DEVICES AND METHODS FOR RESHAPING A BODILY LUMEN
2y 5m to grant Granted Aug 26, 2025
Patent 12376955
ENDOPROSTHESIS WITH STRESS REDUCING FEATURES
2y 5m to grant Granted Aug 05, 2025
Patent 12364592
INTRAOCULAR LENS HAVING A SPECIFIC, THREE-DIMENSIONALLY CURVED HAPTIC ELEMENT
2y 5m to grant Granted Jul 22, 2025
Patent 12343271
LOADING TOOLS FOR PROSTHETIC VALVE DEVICES
2y 5m to grant Granted Jul 01, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
47%
Grant Probability
72%
With Interview (+25.0%)
3y 7m
Median Time to Grant
Low
PTA Risk
Based on 15 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month